Literature DB >> 22735253

Severe hypomagnesemia associated with reversible subacute ataxia and cerebellar hyperintensities on MRI.

Mark I Boulos1, Ashkan Shoamanesh, Richard I Aviv, David J Gladstone, Richard H Swartz.   

Abstract

INTRODUCTION: Hypomagnesemia has been associated with various neurological symptoms including ataxia. Reversible changes in cerebellar function have been described due to hypertensive changes, eclampsia, and immunosuppressive therapy in the context of posterior reversible encephalopathy syndrome. In this report we document isolated, reversible cerebellar findings with the corresponding neuroimaging correlates associated with critically low magnesium levels. CASE REPORT: A 72-year-old male with metastatic colorectal cancer and short gut syndrome presented with subacute ataxia and cerebellar T2 hyperintensities on magnetic resonance imaging. The patient showed rapid clinical and radiologic improvement in his cerebellar findings after receiving only magnesium supplementation.
CONCLUSIONS: Our report suggests that low magnesium levels may mimic the vascular endothelial dysregulation that is seen in the context of rapid rises in blood pressure in both posterior reversible encephalopathy syndrome and eclampsia. This rare case suggests a potential role of magnesium in stabilizing the vascular endothelium and, when deficient, in contributing to cerebral edema of the posterior circulation territories.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22735253     DOI: 10.1097/NRL.0b013e31825bbf07

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  12 in total

1.  Hypomagnesemia: a Treatable Cause of Ataxia with Cerebellar Edema.

Authors:  Idoia Rouco Axpe; Javier Almeida Velasco; Jose Guillermo Barreiro Garcia; Jose Manuel Urbizu Gallardo; Beatriz Mateos Goñi
Journal:  Cerebellum       Date:  2017-12       Impact factor: 3.847

Review 2.  Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2017-05       Impact factor: 5.606

3.  Cerebellar syndrome in chronic cyclic magnesium depletion.

Authors:  Luis Miguel Blasco
Journal:  Cerebellum       Date:  2013-08       Impact factor: 3.847

Review 4.  Reversible cerebellar MRI hyperintensities and ataxia associated with hypomagnesemia: a case report with review of the literature.

Authors:  Rigamonti Andrea; Mantero Vittorio; Lauria Giuseppe; Basilico Paola; Salmaggi Andrea
Journal:  Neurol Sci       Date:  2019-10-27       Impact factor: 3.307

Review 5.  Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature.

Authors:  Joan How; Margaret Blattner; Susan Fowler; Andrea Wang-Gillam; Suzanne E Schindler
Journal:  Neurologist       Date:  2016-11       Impact factor: 1.398

6.  Features of infratentorial-predominant posterior reversible encephalopathy syndrome.

Authors:  Ryan T Fitzgerald; Rohan S Samant; Manoj Kumar; Rudy Van Hemert; Edgardo J Angtuaco
Journal:  Acta Neurol Belg       Date:  2015-01-21       Impact factor: 2.396

7.  Severe hypomagnesaemia causing reversible cerebellopathy.

Authors:  M G E Te Riele; A Verrips
Journal:  Cerebellum       Date:  2014-10       Impact factor: 3.847

8.  Neuro-Ophthalmological Manifestations after Intramuscular Medroxyprogesterone: A Forme Fruste of Idiopathic Intracranial Hypertension?

Authors:  Mandreker Bahall; Antonio Jose Reyes; Kanterpersad Ramcharan; Nadeem Hosein; Karan Seegobin; Krishni Bahall; Hiranyadeva Sharma; Stephanie Dhansingh; Amanda Mahabir
Journal:  Neurol Int       Date:  2016-09-30

9.  Posterior Reversible Encephalopathy Syndrome due to Hypomagnesemia: A Case Report and Literature Review.

Authors:  Mohamad Almoussa; Angelika Goertzen; Stephan Brauckmann; Barbara Fauser; Christoph W Zimmermann
Journal:  Case Rep Med       Date:  2018-11-29

10.  A case report of posterior reversible encephalopathy syndrome in a patient receiving gemcitabine and cisplatin.

Authors:  Hannah Cherniawsky; Neesha Merchant; Micheal Sawyer; Maria Ho
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.